Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
It is generally accepted that the rate of a reaction doubles with increase in temperature of 10 °C. Therefore, the rate of hydrolysis of the twin drugs at 25 °C (incubating temperature applied in in vitro assays) is predicted to be approximately one-half of that at 37 °C.
- 2.
The authors proposed that MDAN-21 (46b) having a longer spacer could bridge the μ and δ receptors in multiple modes and that binding by MDAN-19 (46a) with a shorter linker would be less efficient than that by MDAN-21 (46b). As a result, the acute analgesic potency of 46a would be affected by treatment with NTI.
Abbreviations
- A:
-
Adenosine
- ADME:
-
Absorption, distribution, metabolism, and excretion
- β-FNA:
-
β-Funaltrexamine
- BNTX:
-
7-Benzylidenenaltrexone
- BRET:
-
Bioluminescence resonance energy transfer
- CBM:
-
Cyclobutylmethyl
- CCK:
-
Cholecystokinin
- COS:
-
CV-1 origin SV40 cell
- CPM:
-
Cyclopropylmethyl
- CPP:
-
Conditioned place preference
- DAMGO:
-
[d-Ala2, N-Me-Phe4, Gly-ol]enkephalin
- DCC:
-
Dicyclohexylcarbodiimide
- DML:
-
Designed multiple ligand
- Dmt:
-
2′,6′-Dimethyltyrosine
- DPDPE:
-
Cyclic[d-Pen2, d-Pen5]enkephalin
- EC50 :
-
50% Effective concentration
- ED50 :
-
50% Effective dose
- EDC:
-
1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide
- Emax :
-
% Maximal stimulation
- GNTI:
-
Guanidinonaltrindole
- GPI:
-
Guinea pig ileum
- GTP:
-
Guanosine triphosphate
- HOBt:
-
N-Hydroxybenzotriazole
- 5-HT:
-
5-Hydroxytryptamine (serotonin)
- IBS:
-
Imidazoline binding site
- IC50 :
-
50% Inhibitory concentration
- i.c.v.:
-
Intracerebroventricular
- i.m.:
-
Intramuscular
- Imax :
-
% Maximal inhibition
- i.p.:
-
Intraperitoneal or intraperitoneally
- i.t.:
-
Intrathecal
- i.v.:
-
Intravenous
- MAPK:
-
Mitogen-activated protein kinase
- MS 3A:
-
Molecular sieves 3Ã…
- NMM:
-
N-Methylmorpholine
- nor-BNI:
-
nor-Binaltorphimine
- NSAID:
-
Nonsteroidal anti-inflammatory drug
- NTB:
-
Naltriben
- NTI:
-
Naltrindole
- s.c.:
-
Subcutaneous
- SP:
-
Substance P
- Tic:
-
1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid
References
Contreras J-M, Sippl W (2008) In: Wermuth CG (ed) The practice of medicinal chemistry, 3rd edn. Academic, Amsterdam, pp 380–414
Hazum E, Chang K-J, Cuatrecasas P (1979) Science 206:1077
Portoghese PS, Larson DL, Sayre LM, Yim CB, Ronsisvalle G, Tam SW, Takemori AE (1986) J Med Chem 29:1855
Portoghese PS (2001) J Med Chem 44:2259
Portoghese PS (1989) Trends Pharmacol Sci 10:230
Poetoghese PS (1991) J Med Chem 34:1757
Portoghese PS, Lipkowski AW, Takemori AE (1987) J Med Chem 30:238
Portoghese PS, Nagase H, Lipkowski AW, Larson DL, Takemori AE (1988) J Med Chem 31:836
Portoghese PS, Sultana M, Nagase H, Takemori AE (1988) J Med Chem 31:281
Portoghese PS, Sultana M, Takemori AE (1988) Eur J Pharmacol 146:185
Portoghese PS, Sultana M, Takemori AE (1990) J Med Chem 33:1714
Jordan BA, Devi LA (1999) Nature 399:697
Lavac BAR, O’Dowd BF, George SR (2007) Curr Opin Pharmacol 2:76
Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, Devi LA (2000) J Neurosci 20:RC110
George SR, Fan T, Xie Z, Tse R, Tam V, Varghese G, O’Dowd BF (2000) J Biol Chem 275:26128
Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA (2004) Proc Nat Acad Sci USA 101:5135
Wang D, Sun X, Bohn LM, Sadée W (2005) Mol Pharmacol 67:2173
Devi LA (2001) Trends Pharmacol Sci 22:532 and references cited therein
George SR, O’Dowd BF, Lee SP (2002) Nature Rev Drug Discov 1:808 and references cited therein
Dhawan BN, Cesselin F, Raghubir R, Reisine T, Bradley PB, Portoghese PS, Hamon M (1996) Pharmacol Rev 48:567 and references cited therein
Sato M, Minami M (1995) Pharmacol Ther 68:343 and references cited therein
Morphy R, Kay C, Rankovic Z (2004) Drug Discov Today 9:641
Morphy R, Rankovic Z (2005) J Med Chem 48:6523
Morphy R, Rankovic Z (2008) In: Wermuth CG (ed) The practice of medicinal chemistry, 3rd edn. Academic, Amsterdam, pp 549–571 and references cited therein
Halazy S (1999) Exp Opin Ther Patents 9:431
Peng X, Neumeyer JL (2007) Curr Top Med Chem 7:363
Dietis N, Guerrini R, Calo G, Salvadori S, Rowbotham DJ, Lambert DG (2009) Br J Anaesth 103:38
Ballet S, Pietsch M, Abell AD (2008) Protein Peptide Lett 15:668
Schiller PW (2010) Life Sci 86:598
Negus SS, Mello NK, Portoghese PS, Lin C-E (1997) J Pharmacol Exp Ther 282:44
Mello NK, Negus SS (1998) J Pharmacol Exp Ther 286:812
Bowen CA, Negus SS, Zong R, Neumeyer JL, Bidlack JM, Mello NK (2003) Neuropsychopharmacology 28:1125
Gates M, Montzak TA (1964) J Med Chem 7:129
Neumeyer JL, Bidlack JM, Zong R (2000) J Med Chem 43:114
Neumeyer JL, Zhang A, Xiong W, Gu X-H, Hilbert JE, Knapp BI, Negus S, Mello NK, Bidlack JM (2003) J Med Chem 46:5162
Peng X, Knapp BI, Bidlack JM, Neumeyer JL (2006) J Med Chem 49:256
Decker M, Fulton BS, Zhang B, Knapp BI, Bidlack JM, Neumeyer JL (2009) J Med Chem 52:7389
Decker M, Si Y-G, Knapp BI, Bidlack JM, Neumeyer JL (2010) J Med Chem 53:402
Casy AF, Parfitt RT (1986) Opioid analgesics, chemistry and receptors. Plenum, New York
Fries DS (1995) In: Lemke TL, Williams DA (eds) Foye’s principles of medicinal chemistry, 6th edn. Williams & Wilkins, Philadelphia, pp 652–678
Fulton BS, Knapp BL, Bidlack JM, Neumeyer JL (2010) Bioorg Med Chem Lett 20:1507
Wentland MP, Albertson NF, Pierson AK (1980) J Med Chem 23:71
Hedberg MH, Johansson AM, Fowler CJ, Terenius L, Hacksell U (1994) Bioorg Med Chem Lett 4:2527
Kubota H, Rothman RB, Dersch C, McCullough K, Pinto J, Rice KC (1999) Bioorg Med Chem Lett 8:799
Wentland MP, Xu G, Cioffi CL, Ye Y, Duan W, Cohen DJ, Colasurdo AM, Bidlack JM (2000) Bioorg Med Chem Lett 10:183
McCurdy CR, Jones RM, Portogese PS (2000) Org Lett 2:819
Wentland MP, Duan W, Cohen DJ, Bidlack JM (2000) J Med Chem 46:3558
Wentland MP, Lou R, Ye Y, Cohen DJ, Richardson GP, Bidlack JM (2001) Bioorg Med Chem Lett 11:623
Wentland MP, Lou R, Dehnhardt CM, Duan W, Cohen DJ, Bidlack JM (2001) Bioorg Med Chem Lett 11:1717
Wentland MP, Ye Y, Cioffi CL, Lou R, Zhou Q, Xu G, Duan W, Dehnhardt CM, Sun X, Cohen DJ, Bidlack JM (2003) J Med Chem 46:838
Zhang A, Xiong W, Bidlack JM, Hilbert JE, Knapp BI, Wentland MP, Neumeyer JL (2004) J Med Chem 47:165
Wentland MP, VanAlstine M, Kucejki R, Lou R, Cohen DJ, Parkhill AL, Bidlack JM (2006) J Med Chem 49:5635
Peng X, Knapp BI, Bidlack JM, Neumeyer JL (2007) Bioorg Med Chem Lett 17:1508
Peng X, Knapp BI, Bidlack JM, Neumeyer JL (2007) Bioorg Med Chem 15:4106
Reden J, Reich MF, Rice KC, Jacobson AE, Brossi A (1979) J Med Chem 22:256
Wentland MP, Lu Q, Lou R, Bu Y, Knapp BI, Bidlack JM (2005) Bioorg Med Chem Lett 15:2107
Wentland MP, Lou R, Lu Q, Bu Y, VanAlstine MA, Cohen DJ, Bidlack JM (2009) Bioorg Med Chem Lett 19:203
Wentland MP, Lou R, Lu Q, Bu Y, Denhardt C, Jin J, Ganorkar R, VanAlstine MA, Guo C, Cohen DJ, Bidlack JM (2009) Bioorg Med Chem Lett 19:2289
Portoghese PS, Larson DL, Yim CB, Sayre LM, Ronsisvalle G, Lipkowski AW, Takemori AE, Rice KC, Tam SW (1985) J Med Chem 28:1140
Mathews JL, Peng X, Xiong W, Zhang A, Negus SS, Neumeyer JL, Bidlack JM (2005) J Pharmacol Exp Ther 315:821
Mathews JL, Fulton BS, Negus SS, Neumeyer JL, Bidlack JM (2008) Neurochem Res 33:2142
Reindl JD, Rowan K, Carey AN, Peng X, Neumeyer JL, McLaughlin JP (2008) Pharmacology 81:229
Carlezon WA Jr, Béguin C, DiNieri JA, Baumann MH, Richards MR, Todtenkopf MS, Rothman RB, Ma Z, Lee DY-W, Cohen BM (2006) J Pharmacol Exp Ther 316:440
McLaughlin JP, Land BB, Li S, Pintar JE, Chavkin C (2006) Neuropsychopharmacology 31:787
McLaughlin JP, Marton-Popovici M, Chavkin C (2003) J Neurosci 23:5674
Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, Stevens WC Jr, Jones RM, Portoghese PS, Carlezon WA Jr (2003) J Pharmacol Exp Ther 305:323
Beardsley PM, Howard JL, Shelton KL, Carroll FI (2005) Psychopharmacology 183:118
Salvadori S, Guerrini R, Balboni G, Bianchi C, Bryant SD, Cooper PS, Lazarus LH (1999) J Med Chem 42:5010
Neumeyer JL, Peng X, Knapp BI, Bidlack JM, Lazarus LH, Salvadori S, Trapella C, Balboni G (2006) J Med Chem 49:5640
Peng X, Knapp BI, Bidlack JM, Neumeyer JL (2007) J Med Chem 50:2254
Sayre LM, Portoghese PS (1980) J Org Chem 45:3366
Jones RM, Hjorth JRM, Schwartz TW SA, Portoghese PS (1998) J Med Chem 41:4911
Jones RM, Portoghese PS (2000) Eur J Pharmacol 396:49
Zhang S, Yekkirala A, Tang Y, Portoghese PS (2009) Bioorg Med Chem Lett 19:6978
Portoghese PS, Sultana M, Nelson WL, Klein P, Takemori AE (1992) J Med Chem 35:4086
Poss MA, Iwanowicz E, Reid JA, Lin J, Gu Z (1992) Tetrahedron Lett 33:5933
Kim KY, Qian L (1993) Tetrahedron Lett 34:7677
Garzon J, Juarros JL, Castro MA, Sanchez-Blazquez P (1995) Mol Pharmacol 47:738
Wessendorf MW, Dooyema J (2001) Neurosci Lett 298:151
Portoghese PS, Lunzer MM (2003) Eur J Pharmacol 467:233
Bhushan RG, Sharma SK, Xie Z, Daniels DJ, Portoghese PS (2004) J Med Chem 47:2969
Mosberg HI, Hurst R, Hurby VJ, Gee K, Yamamura HI, Galligan JJ, Burks TF (1983) Proc Natl Acad Sci USA 80:5871
Nock B (1995) In: Tseng LF (ed) The pharmacology of opioid peptides. Harwood Academic Publishers, Singapore, pp 29–56
Simonin F, Slowe S, Becker JAJ, Matthes HWD, Filliol D, Chluba J, Kitchen I, Kieffer BL (2001) Eur J Pharmacol 414:189
Erspamer V, Melchiorri P, Falconieri-Erspamer G, Negri L, Corsi R, Severini C, Barra D, Simmaco M, Kreil G (1989) Proc Natl Acad Sci USA 86:5188
Szmuszkovicz J, Von Voigtlander PF (1982) J Med Chem 25:1125
Xie Z, Bhushan RG, Daniels DJ, Portoghese PS (2005) Mol Pharmacol 68:1079
Barlow JJ, Blackburn TP, Costello GF, James J, Le Count DJ, Main BG, Pearce RJ, Russel K, Shaw JS (1991) J Med Chem 34:3149
Daniels DJ, Kulkarni A, Xie Z, Bhushan RG, Portoghese PS (2005) J Med Chem 48:1713
Sofuoglu M, Portoghese PS, Takemori AE (1991) J Pharmacol Exp Ther 257:676
Portoghese PS, Nagase H, MaloneyHuss KE, Lin C-E, Takemori AE (1991) J Med Chem 34:1715
Portoghese PS, Sultana M, Nagase H, Takemori AE (1992) Eur J Pharmacol 218:195
Ohkawa S, Portoghese PS (1998) J Med Chem 41:4177
Nock B, Giordano AL, Cicero TJ, O’Connor LH (1990) J Pharmacol Exp Ther 254:412
Vaught JL, Takemori A (1979) J Pharmacol Exp Ther 208:86
Vaught JL, Rothman RB, Westfall TC (1982) Life Sci 30:1443
Miyamoto Y, Portoghese PS, Takemori AE (1993) J Pharmacol Exp Ther 264:1141
Abdelhamid EE, Sultana M, Portoghese PS, Takemori AE (1991) J Pharmacol Exp Ther 258:299
Miyamoto Y, Brown WD, Portoghese PS, Takemori AE (1994) J Pharmacol Exp Ther 270:37
Fundytus ME, Schiller PW, Shapiro M, Weltrowska G, Coderre TJ (1995) Eur J Pharmacol 286:105
Daniels DJ, Lenard NR, Etienne CL, Law P-Y, Roerig SC, Portoghese PS (2005) Proc Natl Acad Sci USA 102:19208
Lenard NR, Daniels DJ, Portoghese PS, Roerig SC (2007) Eur J Pharmacol 566:75
Nagase H, Kawamura K, Mizusuna A, Fujii H, Nakatani I (2002) JP 2002332284A
Fujii H, Watanabe A, Nemoto T, Narita M, Miyoshi K, Nakamura A, Suzuki T, Nagase H (2009) Bioorg Med Chem Lett 19:438
Nagase H, Watanabe A, Nemoto T, Yamamoto N, Osa Y, Sato N, Yoza K, Kai T (2007) Tetrahedron Lett 48:2547
Fujii H, Nagase H (2006) Curr Med Chem 13:1109 and references cited therein
Foran SE, Carr DB, Lipkowski AW, Maszczynska I, Marchand JE, Misicka A, Beinborn M, Kopin AS, Kream RM (2000) J Pharmacol Exp Ther 295:1142
Foran SE, Carr DB, Lipkowski AW, Maszczynska I, Marchand JE, Misicka A, Beinborn M, Kopin AS, Kream RM (2000) Proc Natl Acad Sci USA 97:7621
Bonney IM, Foran SE, Marchand JE, Lipkowski AW, Carr DB (2004) Eur J Pharmacol 488:91
Yamamoto T, Nair P, Davis P, Ma S-W, Navratilova E, Moye S, Tumati S (2007) J Med Chem 50:2779
Yamamoto T, Nair P, Vagner J, Largent-Milnes T, Davis P, Ma S-W, Navratilova E (2008) J Med Chem 51:1369
Yamamoto T, Nair P, Jacobsen NE, Davis P, Ma S-W, Navratilova E, Moye S (2008) J Med Chem 51:6334
Hurby VJ, Agnes RS, Davis P, Ma S-W, Lee YS, Vanderah TW, Lai J, Porreca F (2003) Life Sci 73:699
Lee YS, Agnes RS, Badghisi H, Davis P, Ma S-W, Lai J, Porreca F, Hruby VJ (2006) J Med Chem 49:1773
Ndungu JM, Cain JP, Davis P, Ma S-W, Vanderah TW, Lai J, Porreca F, Hruby VJ (2006) Tetrahedron Lett 47:2233
Agnes RS, Lee YS, Davis P, Ma S-W, Badghisi H, Porreca F, Lai J, Hruby VJ (2006) J Med Chem 49:2868
Lee YS, Agnes RS, Davis P, Ma S-W, Badghisi H, Lai J, Porreca F, Hruby VJ (2007) J Med Chem 50:165
Anges RS, Ying J, Kövér KE, Lee YS, Davis P, Ma S-W, Badghisi H, Porreca F, Lai J, Hruby VJ (2008) Peptides 29:1413
Vagner J, Xu L, Handl HL, Josan JS, Morse DL, Mash EA, Gillies RJ, Hruby VJ (2008) Angew Chem Int Ed 47:1685
Dardonville C, Rozas I (2004) Med Res Rev 24:639 and references cited therein
Sánchez-Blázquez P, Boronat MA, Olmos G, GarcÃa-Sevilla JA, Garzón J (2000) Br J Pharmacol 130:146
Fairbanks CA, Posthumus IJ, Kitto KF, Stone LS, Wilcox GL (2000) Pain 84:13
Boronat MA, Olmos G, GarcÃa-Sevilla JA (1998) Br J Pharmacol 125:175
Boronat MA, Olmos G, GarcÃa-Sevilla JA (1999) Ann NY Acad Sci 881:359
Ruiz-Durántez E, Torrecilla M, Pineda J, Ugedo L (2003) Br J Pharmacol 138:494
Morgan AD, Campbell UC, Fons RD, Carroll ME (2002) Pharmacol Biochem Behav 72:873
Rui-Bin SU, Jin LI, Bo-Yi QIN (2003) Acta Pharmacol Sin 24:631
Miralles A, Esteban S, Sastre-Coll A, Moranta D, Asensio VJ, GarcÃa-Sevilla JA (2005) Eur J Pharmacol 518:234
Montero A, Goya P, Jagerovic N, Callado LF, Meana JJ, Girón R, Goicoechea C, MartÃn MI (2002) Bioorg Med Chem 10:1009
Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJ (1994) Science 263:966
Dardonville C, Jagerovic N, Callado LF, Meana JJ (2004) Bioorg Med Chem Lett 14:491
Dardonville C, Fernandez-Fernandez C, Gibbons S-L, Ryan GJ, Jagerovic N, Gabilondo AM, Meana JJ, Callado LF (2006) Bioorg Med Chem 14:6570
Diaz A, Mayet S, Dickenson AH (1997) Eur J Pharmacol 333:9
Lamotte C, Pert CB, Snyder SH (1976) Brain Res 112:407
Hökfelt T, Elde R, Johansson O, Terenius L, Stein L (1977) Neurosci Lett 5:25
Go VL, Yaksh TL (1987) J Physiol 391:141
Duggan AW, Hendry IA, Morton CR, Hutchinson WD, Zhao ZQ (1988) Brain Res 451:261
Kar S, Quirion R (1995) J Comp Neurol 354:253
Minami M, Maekawa K, Yabuuchi K, Satoh M (1995) Mol Brain Res 30:203
Kream RM, Kato T, Shimonaka H, Marchand JE, Wurm WH (1993) Proc Natl Acad Sci USA 90:3564
Maszczynska I, Lipkowski AW, Carr DB, Kream RM (1998) Analgesia 3:1
Kream RM, Liu N-J, Zhuang M, Esposito PL, Esposito TR, Stefano GB, Witmeyer JJ III (2007) Med Sci Monit 13:BR25
Akbarzadeh A, Mehraby M, Zarbakhsh M, Farzaneh H (1999) Biotechnol Appl Biochem 30:139
Itoh S, Katsuura G, Maeda Y (1982) Eur J Pharmacol 80:421
Faris PL, Komisaruk BP, Watkins LR, Mayer DJ (1983) Science 219:310
Wiesinfeld-Hallin Z, Lucas GA, Alster P, Xu X-J, Hokfelt T (1999) Brain Res 848:78
Watkins LR, Kinscheck IB, Mayer DJ (1984) Science 224:395
Suberg SN, Culhane ES, Carstens E, Watkins LR (1985) Ann NY Acad Sci 448:660
Lu L, Huang M, Liu A, Ma L (2000) Neuroreport 11:829
Bock MG, DiPardo RM, Evans BE, Rittle KE, Whitter WL, Garsky VM, Gilbert KF, Leighton JL, Carson KL, Mellin EC, Veber DF, Chang RSL, Lotti VJ, Freedman SB, Smith AJ, Patel S, Anderson PS, Freidiner RM (1993) J Med Chem 36:4276
Zheng Y, Akgün E, Harikumar KG, Hopson J, Powers MD, Lunzer MM, Miller LJ, Portoghese PS (2009) J Med Chem 52:247
Gomes I, Filipovska J, Devi LA (2003) In: Pan ZZ (ed) Opioid research, methods and protocols. Humana, Totowa, pp 165–170
Reider PJ, Davis P, Huges DL, Grabowski EJJ (1987) J Org Chem 52:955
Bock MG, Dipardo RM, Evans BE, Rittle KE, Veber DF, Freidinger RM, Hirshfield J, Sringer JP (1987) J Org Chem 52:3232
Vardanyan R, Vijay G, Nichol GS, Liu L, Kumarasinghe I, Davis P, Vanderah T, Porreca F, Lai J, Hruby VJ (2009) Bioorg Med Chem 17:5044
Shao L, Wang F, Hewitt MC, Barberich TJ (2009) Bioorg Med Chem Lett 19:5679
Mathew SC, Ghosh N, By Y, Berthault A, Virolleaud M-A, Carrega L, Chouraqui G, Commeiras L, Condo J, Attolini M, Gaudel-Siri A, Ruf J, Parrain J-L, Rodriguez J, Guieu R (2009) Bioorg Med Chem Lett 19:6736
O’Brien JG, Gibson F (1970) Biochim Biophys Acta 215:393
Pollack JR, Neilands JB (1970) Biochem Biophys Res Commun 38:989
Brockmann H, Schmidt-Kastner G (1955) Chem Ber 88:57
Nagase H, Watanabe A, Harada M, Nakajima M, Hasebe K, Mochizuki H, Yoza K, Fujii H (2009) Org Lett 11:539
Watanabe A, Fujii H, Nakajima M, Hasebe K, Mochizuki H, Nagase H (2009) Bioorg Med Chem Lett 19:2416
Kerns EH, Di L (2008) Drug-like properties: concepts, structure design and methods: from ADME to toxicity optimization. Academic, New York, pp 37–42
Kerns EH, Di L (2008) Drug-like properties: concepts, structure design and methods: from ADME to toxicity optimization. Academic, New York, pp 122–136
van Rijn RM, Whistler JL (2009) Biol Psychiatry 66:777
Lipkowski AW, Konecka AM, Sroczyńska I (1982) Peptides 3:697
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fujii, H. (2010). Twin and Triplet Drugs in Opioid Research. In: Nagase, H. (eds) Chemistry of Opioids. Topics in Current Chemistry, vol 299. Springer, Berlin, Heidelberg. https://doi.org/10.1007/128_2010_76
Download citation
DOI: https://doi.org/10.1007/128_2010_76
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-18106-1
Online ISBN: 978-3-642-18107-8
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)